Literature DB >> 16427703

Clinical and psychometric characterization of depression in mixed mania: a report from the French National Cohort of 1090 manic patients.

E G Hantouche1, H S Akiskal, J M Azorin, L Châtenet-Duchêne, S Lancrenon.   

Abstract

BACKGROUND: Despite extensive research recently focused on mixed mania, it is uncertain as how best to define it clinically, psychometrically (which has major bearing on its prevalence), and the methodology needed for future research. This topic is also of historical interest, because Magnan (1890) [Magnan, V., 1890. La Folie Intermittente. G Masson, Paris.] suggested that "combined [mixed] states" linked Falret's "circular insanity" with Baillarger's "dual insanity" (both described in 1854). This work eventually led to the Kraepelinian synthesis of all manic, mixed, and depressive states into the unitary rubric of "manic-depressive insanity (1899/1921).
METHOD: EPIMAN-II Thousand" (EPIMAN-II MILLE) is a French national collaborative study, which involved training 317 psychiatrists working in different sites representative of psychiatric practice in France. We recruited 1090 patients hospitalized for acute DSM-IV mania. assessed at index admission by the following measures: the Mania Rating Scale (MRS), the Beigel-Murphy Scale (MSRS), a newly derived checklist of depressive symptoms least contaminated by mania, MADRS for severity of depression, and the SAPS for psychotic features.
RESULTS: The rate of mixed mania, as defined by at least 2 depressive symptoms, was 30%. Even with this broad definition, we found significantly higher female representation. This clinical sub-type of mania was characterized by high frequency of past diagnostic errors, particularly those of anxiety and personality disorders. Refined definition of co-exiting depression was obtained from an abbreviated version of the MADRS (6 items), with distinct "emotional-cognitive" symptoms, and "psychomotor inhibition" factors, both of which were separable from an "irritable" factor linked to lability and poor judgment. Mixed mania was psychometrically best identified by a MADRS score of 6 (80% sensitivity, 94% specificity) and validated by a mixed polarity of first episodes, a higher rate of recurrence, psychotic features, and suicide attempts. LIMITATION: Cross-sectional study.
CONCLUSIONS: The data deriving from EPIMAN, the largest and only national study ever conducted on mania, provide definitive characterization of the clinical and psychotic structure of mixed mania, which accounts for 1 out of 3 patients who present with mania. This figure is more accurate than higher rates reported in the literature because, in describing "mixity", we eliminated depressive features that could be contaminated by mania. Despite the prominent affective features described herein, the bipolar nature of mixed mania is often missed, with the result that these patients are diagnosed as having anxiety and/or personality disorders. It is of great public health significance for psychiatrists to recognize the bipolar nature of this condition that has been known as a major phase of manic-depressive illness since at least Magnan, a disciple of Falret and Baillarger.

Entities:  

Mesh:

Year:  2006        PMID: 16427703     DOI: 10.1016/j.jad.2005.01.005

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  13 in total

1.  Toward the delineation of mania subtypes in the French National EPIMAN-II Mille Cohort. Comparisons with prior cluster analytic investigations.

Authors:  Jean-Michel Azorin; Arthur Kaladjian; Marc Adida; Elie Hantouche; Ahcene Hameg; Sylvie Lancrenon; Hagop Souren Akiskal
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-20       Impact factor: 5.270

Review 2.  The significance of mixed states in depression and mania.

Authors:  Giulio Perugi; Giuseppe Quaranta; Liliana Dell'Osso
Journal:  Curr Psychiatry Rep       Date:  2014-10       Impact factor: 5.285

3.  Does the efficacy of asenapine in bipolar disorder increase in the presence of comorbidity with a substance use disorder? A naturalistic study.

Authors:  Sergio De Filippis; Ilaria Cuomo; Georgios D Kotzalidis; Daniela Pucci; Pietro Zingaretti; Raffaella Porrari; Camilla Fini; Paola Motta; Matteo Caloro; Paolo Girardi
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-28

4.  The structure of psychopathology: toward an expanded quantitative empirical model.

Authors:  Aidan G C Wright; Robert F Krueger; Megan J Hobbs; Kristian E Markon; Nicholas R Eaton; Tim Slade
Journal:  J Abnorm Psychol       Date:  2012-10-15

Review 5.  Epidemiology, diagnosis and management of mixed mania.

Authors:  Ana González-Pinto; Ana Aldama; Fernando Mosquera; Cristina González Gómez
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Number of prior episodes and the presence of depressive symptoms are associated with longer length of stay for patients with acute manic episodes.

Authors:  Manuel Martin-Carrasco; Ana Gonzalez-Pinto; Jaime L Galan; Javier Ballesteros; Jorge Maurino; Eduard Vieta
Journal:  Ann Gen Psychiatry       Date:  2012-03-10       Impact factor: 3.455

7.  Evaluating depressive symptoms in mania: a naturalistic study of patients with bipolar disorder.

Authors:  Allan H Young; Jonas Eberhard
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-29       Impact factor: 2.570

8.  Mixed states vs. pure mania in the French sample of the EMBLEM study: results at baseline and 24 months--European mania in bipolar longitudinal evaluation of medication.

Authors:  Jean-Michel Azorin; Elodie Aubrun; Jordan Bertsch; Catherine Reed; Stephanie Gerard; Michael Lukasiewicz
Journal:  BMC Psychiatry       Date:  2009-06-07       Impact factor: 3.630

9.  Inhibition/activation in bipolar disorder: validation of the Multidimensional Assessment of Thymic States scale (MAThyS).

Authors:  Chantal Henry; Amandine Luquiens; Christophe Lançon; Hélène Sapin; Marcel Zins-Ritter; Stephanie Gerard; Elena Perrin; Bruno Falissard; Michael Lukasiewicz
Journal:  BMC Psychiatry       Date:  2013-03-13       Impact factor: 3.630

10.  Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder.

Authors:  A Carlo Altamura; Jose M Goikolea
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.